ACT-132577

aprocitentan · Idorsia Pharmaceuticals Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT-132577, covering 2020-04-13 to 2020-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension [Phase 2]